EcoDrugPlus

Solute Carrier Family 6 Member 4

Ensembl ID : ENSBTAG00000019349
Gene Symbol: SLC6A4
4 Enzyme and pathways 5 Cross references
217 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSBTAG00000008690
Gene Symbol: SLC6A9
4 Enzyme and pathways 4 Cross references
211 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSBTAG00000004629
Gene Symbol: SLC9A3
4 Enzyme and pathways 5 Cross references
250 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSBTAG00000006582
Gene Symbol: SSTR1
7 Enzyme and pathways 3 Cross references
172 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSBTAG00000017136
Gene Symbol: SSTR2
7 Enzyme and pathways 5 Cross references
276 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSBTAG00000008910
Gene Symbol: SSTR3
11 Enzyme and pathways 5 Cross references
262 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSBTAG00000039974
Gene Symbol: SSTR5
7 Enzyme and pathways 5 Cross references
261 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSBTAG00000009872
Gene Symbol: SPHK2
4 Enzyme and pathways 5 Cross references
221 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSBTAG00000005990
Gene Symbol: S1PR1
5 Enzyme and pathways 5 Cross references
206 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSBTAG00000004767
Gene Symbol: SYK
32 Enzyme and pathways 5 Cross references
212 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSBTAG00000054516
Gene Symbol: LOC112444495
6 Enzyme and pathways 4 Cross references
217 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSBTAG00000003108
Gene Symbol: SRD5A2
5 Enzyme and pathways 5 Cross references
278 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).